Deepak Chemtex Ltd
Incorporated in 1997, Deepak Chemtex manufactures colourants used in food, pharmaceuticals, cosmetics, confectionery,
feeds and ink jet inks[1]
- Market Cap ₹ 91.5 Cr.
- Current Price ₹ 84.2
- High / Low ₹ 170 / 82.0
- Stock P/E 8.23
- Book Value ₹ 55.0
- Dividend Yield 0.00 %
- ROCE 33.8 %
- ROE 25.8 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 27.4%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|
| 54 | 46 | 49 | 78 | 72 | |
| 48 | 39 | 41 | 62 | 57 | |
| Operating Profit | 6 | 8 | 8 | 16 | 15 |
| OPM % | 11% | 17% | 16% | 21% | 21% |
| 0 | 1 | 1 | 3 | 3 | |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | 6 | 8 | 8 | 17 | 15 |
| Tax % | 25% | 25% | 27% | 25% | |
| 4 | 6 | 6 | 13 | 11 | |
| EPS in Rs | 5.50 | 11.52 | 10.23 | ||
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 13% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 44% |
| TTM: | 32% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -21% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 27% |
| Last Year: | 26% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 0.50 | 0.50 | 11 | 11 | 11 |
| Reserves | 9 | 15 | 31 | 44 | 49 |
| 2 | 1 | 2 | 1 | 1 | |
| 6 | 7 | 7 | 14 | 7 | |
| Total Liabilities | 17 | 24 | 51 | 70 | 67 |
| 3 | 4 | 8 | 13 | 13 | |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| 14 | 19 | 43 | 57 | 54 | |
| Total Assets | 17 | 24 | 51 | 70 | 67 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 1 | 3 | 2 | -3 | |
| -1 | -2 | -4 | -16 | |
| 0 | -1 | 20 | -1 | |
| Net Cash Flow | 0 | 1 | 19 | -21 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 57 | 88 | 107 | 94 |
| Inventory Days | 21 | 54 | 82 | 89 |
| Days Payable | 37 | 54 | 51 | 51 |
| Cash Conversion Cycle | 41 | 88 | 138 | 132 |
| Working Capital Days | 42 | 81 | 109 | 125 |
| ROCE % | 58% | 28% | 34% |
Insights
In beta| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Installed Capacity MTPA ・Standalone data |
|
||||
| Actual Production MT ・Standalone data |
|||||
| Capacity Utilization Rate % ・Standalone data |
|||||
| Product Portfolio (SKUs) Number ・Standalone data |
|||||
| Revenue Concentration from Top 10 Products % ・Standalone data |
|||||
| Total Employees Number ・Standalone data |
|||||
| Domestic Customers Number ・Standalone data |
|||||
| Global Customers Number ・Standalone data |
|||||
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
12 Jan - Certificate under Reg 74(5): all shares in demat; no rematerialisation requests for quarter ended Dec 31, 2025.
- Unaudited Financial Results Of The Company For Half Year Ended September 30, 2025 14 Nov 2025
-
Statement Of Deviation & Variation For Half Year Ended September 30, 2025
14 Nov 2025 - IPO proceeds Rs.2,304.00 lakh fully utilised; no deviation as of Sep 30, 2025.
-
Board Meeting Outcome for Held On Friday, November 14, 2025
14 Nov 2025 - Board approved H1 (Sep 30, 2025) results: consolidated income ₹3,172.41 lakh, PAT ₹432.97 lakh; IPO proceeds fully utilized (₹2,304.00 lakh).
-
Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results Of The Company For Half Year Ended On September 30, 2025
5 Nov 2025 - Board meeting on Nov 14, 2025 to approve unaudited results for half-year ended Sept 30, 2025.
Business Overview:[1]
DCL specializes in manufacturing, refining, exporting, importing, and trading chemical products, including:
a) Inorganic Acids and Chemicals:
- Sulphuric acid, oleum, chloro-
sulphonic acid, hydrochloric acid
- Various grades of alums, pyrites,
gypsum, bauxite, alumina, and
aluminium hydroxide
- Aluminium compounds, sulphur,
zinc, copper, and magnesium
b) Sulphates and Industrial Chemicals:
- Zinc sulphate, copper sulphate,
magnesium sulphate, and other
sulphates
- Hydrogen, chlorine, and related
industrial chemicals
b) Specialized Products:
Fertilizers, pesticides, pharmaceuticals, polymers, plastics, detergents, dyes, and essences